Skip to content

Advertisement

  • Case report
  • Open Access
  • Open Peer Review

Multiple focal and macroreentrant left atrial tachycardias originating from a spontaneous scar at the contiguous aorta-left atrium area in a patient with hypertrophic cardiomyopathy: a case report

BMC Cardiovascular DisordersBMC series – open, inclusive and trusted201717:29

https://doi.org/10.1186/s12872-016-0448-3

  • Received: 7 September 2016
  • Accepted: 16 December 2016
  • Published:
Open Peer Review reports

Abstract

Background

Spontaneous scar-related left atrial tachycardia (AT) is a rare arrhythmia. We describe a patient with hypertrophic cardiomyopathy (HCM) who developed multiple, both focal and macroreentrant left ATs associated with a spontaneous scar located at the aorta-left atrium (LA) contiguous area.

Case presentation

A 65-year-old man with HCM complained of palpitations. Twelve-lead electrocardiogram showed narrow QRS tachycardia with 2:1 atrioventricular conduction. Two sessions of radiofrequency ablation (RFA) were required to eliminate all left ATs. In the first session, 3-dimensional electroanatomical mapping fused with the image constructed by multi-detector computed tomography showed a clockwise macroreentrant AT (AT1) associated with a low-voltage or dense scar area located along the aorta-LA contiguous area. AT1 was eliminated by RFA to the narrow isthmus with slow conduction velocity within the scar. Additional ATs (AT2-AT4) occurred 1 month after the first ablation. In the second session, AT2 and AT3 were identified as focal ATs with centrifugal propagation and few accompanying fragmentations, and AT4 as a macroreentrant AT with features similar to AT1. AT2 and AT3 were successfully eliminated by performing RFA to the earliest activation site, and AT4 was terminated by performing RFA to the narrow isthmus with slow conduction velocity. No ATs have recurred for 11 months after these RFAs. Interestingly, the substrate for all left ATs was associated with the aorta-LA contiguous area.

Conclusion

To our knowledge, this is the first case of multiple, both focal and macroreentrant left ATs associated with a contiguous aorta-LA spontaneous scar area in a patient with HCM.

Keywords

  • Case report
  • Atrial tachycardia
  • Contiguous aorta-left atrium area
  • Spontaneous scar
  • Hypertrophic cardiomyopathy
  • 3-D electroanatomical mapping

Background

The treatment of atrial tachycardia (AT) is important because, similar to atrial fibrillation [1], AT can lead to poor outcomes in patients with hypertrophic cardiomyopathy (HCM) [2]. While most ATs originating from the left atrium (LA) occur in association with a procedure-related scar due to cardiac surgery or catheter ablation [35], left ATs related to a non-procedure-related spontaneous scar have been reported in association with a substrate in the LA anterior wall [6]. A rigid aorta-LA connection exists, which may promote myocardial fibrosis [7, 8]. ATs are often classified according to their endocardial activation pattern as follows: (1) focal ATs, spreading centrifugally from the tachycardia origin based on microreentry, automaticity, or triggered activity, and (2) macroreentrant ATs with a continuous loop of the electrical wavelet based on macroreentry [9]. Scar-related ATs can be classified as either pattern. However, clinical reports particularly concerning spontaneous LA scars are limited.

Here, we describe a patient with HCM who had both focal and macroreentrant multiple ATs associated with a spontaneous scar at the contiguous aorta-LA region that were successfully ablated using 3-D electroanatomical mapping fused with the image constructed using multi-detector computed tomography (MDCT).

Case presentation

A 65-year-old patient with HCM and a history of common atrial flutter ablation was referred to our clinic with complaints of recurrent shortness of breath and palpitations. Two years prior, echocardiogram showed HCM with a preserved left ventricular ejection fraction and a slightly enlarged LA; coronary angiogram showed intact coronary arteries, and results of a right ventricular myocardial biopsy showed mildly hypertrophic myocardium with mild fibrosis at the subendomyocardium and peri-vascular area. A concomitant cavotricuspid-isthmus-dependent atrial flutter was eliminated by performing linear ablation between the tricuspid annulus through the inferior vena cava during the same hospitalization.

Two years later, he again developed atrial arrhythmia. Twelve-lead electrocardiogram showed AT (AT1) with 2:1 atrioventricular conduction (Fig. 1a). An electrophysiological study was subsequently conducted. A 10-polar electrode catheter (Response™, St. Jude Medical Co., Ltd., Minnesota, USA) was placed in the coronary sinus (CS), and a 20-polar electrode catheter (LiveWire™, St. Jude Medical Co., Ltd.) was placed along the tricuspid annulus. Intracardiac electrograms were filtered at 50–500 Hz. Electroanatomical mapping was performed using a 3-D electroanatomical mapping system (Ensite NavX™, St. Jude Medical Co., Ltd.). AT1 persisted from the beginning of the first session with a tachycardia cycle length (TCL) of 248 ms. Because the atrial activation pattern in the CS electrode was detected distal to the proximal sequence and the CS distal activation was earlier than the earliest activation site within the right atrium, we concluded that AT1 originated from the LA. A multipolar ring catheter (Reflection spiral™, St. Jude Medical Co., Ltd.) and a 4-mm open-irrigated-tip catheter (FlexAbility™, St. Jude Medical. Co., Ltd.) were inserted into the LA through a single transseptal puncture. Further activation mapping of the LA demonstrated that AT1 propagated in a figure-eight configuration around the mitral annulus clockwise, and the total activation time of AT1 accounted for almost the entire TCL (Additional file 1; Fig. 2a). 3-D electroanatomical voltage mapping fused with the constructed MDCT image showed a low-voltage (<0.5 mV), dense scar (<0.05 mV) area along the aorta-LA contiguous area from the mid-LA anterior wall through the anterior mitral annulus (Fig. 3); activation mapping indicated that this spontaneous scar area was related to the slow conduction zone for the AT1 circuit. We concluded that AT1 was a macroreentrant AT dependent on the isthmus located along the aorta-LA contiguous area; subsequent radiofrequency ablation (RFA) confirmed the existence of the circuit point-by-point in the entrainment study. AT1 was terminated by RFA at the site near the mitral annulus where a preceding local potential 110 ms before the P-wave onset and post-pacing interval were equal to the TCL during the entrainment study. AT1 and the other ATs could not be provoked again during this session by burst pacing with or without isoproterenol infusion. Due to the severity of the patient’s heart failure, a minimally invasive procedure was preferred; hence, additional RFA was not conducted during the first session.

Additional file 1. Propagation mapping of atrial tachycardia 1. (MPG 2006 kb)

Fig. 1
Fig. 1

a 12-lead electrocardiogram (ECG) showing narrow QRS tachycardia with 2:1 atrioventricular conduction. A saw-tooth wave was detected by the inferior lead, and the tachycardia cycle length (TCL) was 240 ms. b ECG showing narrow QRS tachycardia with 2:1 atrioventricular conduction. P-wave deflection was negative in V1, and the TCL was 286 ms

Fig. 2
Fig. 2

Activation mapping during multiple atrial tachycardias: atrial tachycardia (AT)1 (a), AT2 (b), AT3 (c) and AT4 (d). The activation patterns of AT1 and AT4 showed macroreentry. AT1 and AT4 were terminated by performing radiofrequency ablation at the red circle where a long-duration, fractionated potential was recorded. The white circles represent the unsuccessful site for terminating AT. AT2 and AT3, which had a centrifugal pattern, were terminated at the early activation site where the local potentials preceded the P-wave onset. Abl-d = distal ablation electrode; Abl-p = proximal ablation electrode; CS-p = proximal coronary sinus electrode; CS-d = distal coronary sinus electrode

Fig. 3
Fig. 3

Electroanatomical voltage mapping fused with MDCT. A low-voltage area existed along the aorta-left atrium contiguous region. Termination of the atrial tachycardias (AT1-4) was achieved at the points indicated by the yellow circles

One month later, another AT with a longer TCL of 286 ms (AT2) occurred (Fig. 1b), and the patient developed worsening heart failure. A second electrophysiological session was performed with the same system settings. AT2 was reproducibly provoked by atrial burst pacing without isoproterenol infusion. Activation mapping showed a centrifugal pattern with the origin located at the border of the aorta-LA contiguous, low-voltage area of the mid-anterior LA wall, different from the prior ablation points for AT1 (Additional file 2). Several entrainment studies could not demonstrate manifest entrainment, and there was no fragmented potential that accounted for almost the entire TCL around the earliest activation site. AT2 was terminated by performing RFA at the earliest atrial activation site (Fig. 2b). A third AT with a TCL of 330 ms (AT3) was easily and reproducibly provoked by burst pacing without isoproterenol infusion. AT3 also had centrifugal propagation similar to AT2 (Additional file 3). AT3 was successfully terminated by performing a single RFA at the earliest activation site near the AT2 ablation site (Fig. 2c). A fourth AT with a TCL of 350 ms (AT4) was also provoked by burst pacing without isoproterenol infusion; however, electroanatomical activation mapping of AT4 showed macroreentry in a clockwise fashion, mimicking peri-mitral flutter, similar to AT1 (Additional file 4; Fig. 2d). The critical isthmus of AT4 was located near the upper edge of the prior ablation area for AT1 where the long-duration, fractionated potential that accounted for about 70% of the TCL was recorded and the post-pacing interval was equal to the TCL during the entrainment study. This narrow isthmus was located between the dense scar and upper edge of a prior ablation area. A single RFA at this site terminated AT4, and AT4 was never provoked again by burst pacing with or without isoproterenol infusion. We aimed to achieve noninducibility of ATs, instead of creating a complete block line, because minimal procedures were required due to the severity of the patient’s heart failure.

Additional file 2. Propagation mapping of atrial tachycardia 2. (MPG 874 kb)

Additional file 3. Propagation mapping of atrial tachycardia 3. (MPG 1381 kb)

Additional file 4. Propagation mapping of atrial tachycardia 4. (MPG 1277 kb)

No ATs have recurred in this patient, up to 11 months after these interventions.

Discussion

The present case demonstrates two important issues: (1) a large spontaneous scar can exist along the aorto-LA contiguous region in the LA that can be arrhythmogenic; (2) multiple ATs with two different activation patterns - both focal and macroreentrant - can occur in association with a spontaneous scar in the LA.

In contrast to the right atrium, the LA has few anatomical obstacles [10]. However, a spontaneous scar can arise in the LA and can act as an arrhythmia substrate [11]. The most common region for a spontaneous scar to develop is the aorta-LA contiguous area; in this region, rigid contact between the aorta and LA exits, which can promote fibrosis and lead to scar formation [12, 13]. Hori Y. et al. demonstrated 68% of the LA very low voltage area (<0.2 mV) overlapped with areas of the LA that contact external anatomical structures, such as the aorta and vertebra, suggesting that contact with external anatomical structures may influence scar formation [13]. Wakabayashi Y. et al. reported a patient with HCM who had a spontaneous scar in the LA anterior wall in contact with the right pulmonary artery, implying that HCM-induced pressure overload might contribute to remodeling and fibrosis [6]. In the present case, heterogeneous myocardial damage, including a wide aorta-LA contiguous scar area and electrically normal posterior LA wall, was observed, suggesting that mechanical stress due to the rigid connection played a more important role than pressure overload in fibrosis and scar formation of the LA. Interestingly, HCM itself plays a potential role in promoting myocardial fibrosis and scar formation. In addition to the genetic background of HCM, it has been reported that transforming growth factor-β1, a potent stimulator of collagen-producing cardiac fibroblasts that also stimulates the differentiation of fibroblasts into more active myofibroblasts, is highly expressed in the myocardium of patients with HCM, implying that HCM increases the susceptibility to triggers that promote myocardial fibrosis [1417]. Therefore, when cardiologists plan a therapeutic strategy for a patient with HCM who has various left ATs, they should consider the possibility of an existing spontaneous scar and its possible role as an arrhythmogenic substrate even if the patient has no history of surgical interventions to the LA.

Regarding the mechanism of AT from an electrophysiological aspect, macroreentry and microreentry have been reported in association with a spontaneous scar [7, 11]. In cases of spontaneous scar, the aorta-LA contiguous scar area has been reported to be involved in the reentry circuit of localized reentrant AT [12]. However, other mechanisms, such as automaticity and triggered activity, may also be involved in the arrhythmogenesis of ATs due to scar [18]. Furthermore, the mechanical stretch induced by LA enlargement itself may cause changes in cellular action potential and calcium current, which potentially alter the arrhythmogenicity of the tissue [19]. Considering the underlying mechanism of ATs in the present case, AT1 and AT4 (recurrence of AT1) were based on macroreentry, as depicted on activation mapping. AT2 and AT3 were focal ATs depicted as centrifugal propagation. After assessing the underlying mechanism of AT2 and AT3 in the present case, the following observations suggest the likelihood of triggered activity other than microreentry or automaticity: (1) AT2 and AT3 were easily provoked by burst pacing without isoproterenol; (2) no gradual acceleration and/or slowing, known as the warm up or cool down phenomenon, was observed; (3) no manifest entrainment was observed; and (4) no fractionated potential accounting for almost the entire TCL was observed around the earliest activation site of those ATs. While it is often difficult to identify the underlying mechanism of ATs in clinical practice [20, 21], we consider it important to assess the arrhythmia etiology and its mechanisms in order to provide appropriate comprehensive treatment. Because the present case implies the possible arrhythmogenesis of focal ATs, unlike microreentry from a spontaneous scar in the LA, we considered it important to remember that multiple ATs of various mechanisms can arise in association with a spontaneous scar.

The 3-D electroanatomical mapping fused with the image constructed by MDCT is the preferred modality for visualization of tachyarrhythmia propagation in relation to anatomical information. This modality is useful not only in planning the ablation strategy but also in understanding the relationship between anatomical obstacles and the injured myocardium, including low-voltage or silent areas as encountered in the present case. Therefore, we think it is best to use 3-D electroanatomical mapping fused with the image constructed by MDCT when planning ablation treatment for patients with multiple and various ATs associated with an atrial scar.

The case information presented here is beneficial to cardiologists, who should be aware of the possibility that focal and macroreentrant left ATs can occur in association with a spontaneous scar, especially in patients with HCM, even if they have no history of invasive intervention to the LA.

Conclusion

We have reported a case of multiple LA-AT associated with the aorta–LA contiguous low-voltage area and apparently involving various kinds of pathophysiology. Three-dimensional electroanatomical mapping fused with multidetector computed tomography is useful for visualizing the relation between the aorta and the LA low-voltage area.

Abbreviations

AT: 

Atrial tachycardia

CS: 

Coronary sinus

ECG: 

Electrocardiogram

HCM: 

Hypertrophic cardiomyopathy

LA: 

Left atrium

MDCT: 

Multi-detector computed tomography

RFA: 

Radiofrequency application

RFCA: 

Radiofrequency catheter ablation

TCL: 

Tachycardia cycle length

Declarations

Acknowledgement

We thank Editage (www.editage.jp) for English language editing.

Funding

The English editing and publishing fees were covered by the Clinical Research Division of Yokohama Medical Center.

Availability of data and materials

All the data supporting our findings are contained within the manuscript.

Authors’ contributions

Clinical data collection and interpretation: KY, YA, FM. Drafting: KY. Editing and revision: KY and YA. Final approval: KY, YA, FM, MW, KT, KM, TS, and KI. Funding: KI. All authors read and approved the final manuscript.

Competing interests

Yoichi Ajiro received rewards for supporting other research performed at St. Jude Medical, Co., Ltd. (Japan). The other authors declare that they have competing interests.

Consent for publication

Written informed consent was obtained from the patient.

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the local ethics committee of Yokohama Medical Center and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Cardiology, National Hospital Organization Yokohama Medical Center, 3-60-2 Harajuku, Totsuka-ku, Yokohama-shi Kanagawa, 245-8575, Japan

References

  1. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517–24.View ArticlePubMedGoogle Scholar
  2. Boolani H, Reddy YM, Ittaman S, Lakkireddy D. Recurrent unilateral pleural effusion in a hypertrophic cardiomyopathy patient secondary to atrial arrhythmias and the role of radiofrequency ablation. Europace. 2012;14(9):1371–2.View ArticlePubMedGoogle Scholar
  3. Duru F, Hindricks G, Kottkamp H. Atypical left atrial flutter after intraoperative radiofrequency ablation of chronic atrial fibrillation: successful ablation using three-dimensional electroanatomic mapping. J Cardiovasc Electrophysiol. 2001;12(5):602–5.View ArticlePubMedGoogle Scholar
  4. Kalman JM, VanHare GF, Olgin JE, Saxon LA, Stark SI, Lesh MD. Ablation of ‘incisional’ reentrant atrial tachycardia complicating surgery for congenital heart disease. Use of entrainment to define a critical isthmus of conduction. Circulation. 1996;93(3):502–12.View ArticlePubMedGoogle Scholar
  5. Ejima K, Shoda M, Miyazaki S, Yashiro B, Wakisaka O, Manaka T, Hagiwara N. Localized reentrant tachycardia in the aorta contiguity region mimicking perimitral atrial flutter in the context of atrial fibrillation ablation. Heart Vessel. 2013;28(4):546–9.View ArticleGoogle Scholar
  6. Wakabayashi Y, Hayashi T, Mitsuhashi T, Momomura S-I. Localized reentrant atrial tachycardia without a history of catheter ablation in a patient with apical hypertrophic cardiomyopathy. Circ J. 2014;78(12):2990–2.View ArticlePubMedGoogle Scholar
  7. Fukamizu S, Sakurada H, Hayashi T, Hojo R, Komiyama K, Tanabe Y, Tejima T, Nishizaki M, Kobayashi Y, Hiraoka M. Macroreentrant atrial tachycardia in patients without previous atrial surgery or catheter ablation: clinical and electrophysiological characteristics of scar-related left atrial anterior wall reentry. J Cardiovasc Electrophysiol. 2013;24(4):404–12.View ArticlePubMedGoogle Scholar
  8. Pak HN, Oh YS, Lim HE, Kim YH, Hwang C. Comparison of voltage map-guided left atrial anterior wall ablation versus left lateral mitral isthmus ablation in patients with persistent atrial fibrillation. Heart Rhythm. 2011;8(2):199–206.View ArticlePubMedGoogle Scholar
  9. Zhou G-B, Hu J-Q, Guo X-G, Liu X, Yang J-D, Sun Q, Ma J, Ouyang F-F, Zhang S. Very long-term outcome of catheter ablation of post-incisional atrial tachycardia: Role of incisional and non-incisional scar. Int J Cardiol. 2016;205:72–80.View ArticlePubMedGoogle Scholar
  10. Feld GK, Shahandeh-Rad F. Activation patterns in experimental canine atrial flutter produced by right atrial crush injury. J Am Coll Cardiol. 1992;20(2):441–51.View ArticlePubMedGoogle Scholar
  11. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S, Schweikert RA, Saliba W, Cummings J, Burkhardt JD, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol. 2005;45(2):285–92.View ArticlePubMedGoogle Scholar
  12. Maeda S, Yamauchi Y, Tao S, Okada H, Obayashi T, Hirao K. Small reentrant atrial tachycardia adjacent to left aortic sinus of Valsalva. Circ J. 2013;77(12):3054–5.View ArticlePubMedGoogle Scholar
  13. Hori Y, Nakahara S, Kamijima T, Tsukada N, Hayashi A, Kobayashi S, Sakai Y, Taguchi I. Influence of left atrium anatomical contact area in persistent atrial fibrillation. Circ J. 2014;78(8):1851–7.View ArticlePubMedGoogle Scholar
  14. Li G, Li RK, Mickle DA, Weisel RD, Merante F, Ball WT, Christakis GT, Cusimano RJ, Williams WG. Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism. Circulation. 1998;98(19 Suppl):II144–9. discussion II149-50.PubMedGoogle Scholar
  15. Ayca B, Sahin I, Kucuk SH, Akin F, Kafadar D, Avsar M, Avci II, Gungor B, Okuyan E, Dinckal MH. Increased transforming growth factor-beta levels associated with cardiac adverse events in hypertrophic cardiomyopathy. Clin Cardiol. 2015;38(6):371–7.View ArticlePubMedGoogle Scholar
  16. Lijnen P, Petrov V. Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol. 2002;24(6):333–44.View ArticlePubMedGoogle Scholar
  17. Li G, Borger MA, Williams WG, Weisel RD, Mickle DAG, Wigle ED, Li R-K. Regional overexpression of insulin-like growth factor-I and transforming growth factor-β1 in the myocardium of patients with hypertrophic obstructive cardiomyopathy. J Thorac Cardiovasc Surg. 2002;123(1):89–95.View ArticlePubMedGoogle Scholar
  18. Mary-Rabine L, Hordof AJ, Danilo P, Malm JR, Rosen MR. Mechanisms for impulse initiation in isolated human atrial fibers. Circ Res. 1980;47(2):267–77.View ArticlePubMedGoogle Scholar
  19. Deroubaix E, Folliguet T, Rucker-Martin C, Dinanian S, Boixel C, Validire P, Daniel P, Capderou A, Hatem SN. Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability. J Am Coll Cardiol. 2004;44(9):1918–26.View ArticlePubMedGoogle Scholar
  20. Higa S, Chen S-A. Focal atrial tachycardia. J Arrhythm. 2006;22(3):132–48.View ArticleGoogle Scholar
  21. Higa S, Tai CT, Lin YJ, Liu TY, Lee PC, Huang JL, Hsieh MH, Yuniadi Y, Huang BH, Lee SH, et al. Focal atrial tachycardia: new insight from noncontact mapping and catheter ablation. Circulation. 2004;109(1):84–91.View ArticlePubMedGoogle Scholar

Copyright

Advertisement